Evidence map›Paper›PMID 21182085›Full record

ArticleEuropean journal of immunology2011

Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease.

Sienmi Du, Francisco Sandoval, Pauline Trinh, Elizabeth Umeda, Rhonda Voskuhl

Abstract read
In one paragraph

Article in European journal of immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Neuroprotection in Cerebral Cortex Induced by the Pregnancy Hormone Estriol.Laboratory investigation; a journal of technical methods and pathology · 2023
    Article
  3. Article
  4. Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Estrogen effects in allergy and asthma.Current opinion in allergy and clinical immunology · 2013
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Sienmi DuUCLA Department of Physiological Sciences, Los Angeles, CA 90095, USA.
Francisco Sandoval
Pauline Trinh
Elizabeth Umeda
Rhonda Voskuhl
University of California, Los Angeles · US

Funding

Treatment of Multiple Sclerosis with Sex HormonesK24NS062117 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VOSKUHL, RHONDA R · 2008 to 2012
$722k
NINDS NIH HHS K24 NS062117NINDS NIH HHS K24NS062117
6 · The paper itself

Abstract

Estrogens act upon nuclear estrogen receptors (ER) to ameliorate cell-mediated autoimmune disease. As most immunomodulatory effects of estrogens in EAE have been attributed to the function of ER-α, we previously demonstrated that ER-β ligand treatment reduced disease severity without affecting peripheral cytokine production or levels of CNS inflammation, suggesting a direct neuroprotective effect; however, the effect of ER-β treatment on the function of immune cells within the target organ remained unknown. Here, we used adoptive transfer studies to show that ER-β ligand treatment was protective in the effector, but not the induction phase of EAE, as shown by decreased clinical disease severity with the preservation of axons and myelin in spinal cords. The analysis of the immune cell infiltrates in the CNS revealed that while ER-β ligand treatment did not reduce overall levels of CNS inflammation, there was a decrease in the DC percentage, and these CNS DC had decreased TNF-α production. Finally, experiments using DC deficient in ER-β revealed that the expression of ER-β on DC was essential for protective effects of ER-β ligand treatment in EAE. Our results demonstrate for the first time an effect of ER-β ligand treatment in vivo on DC in the target organ of a prototypic cell-mediated autoimmune disease.

Indexed as

Adoptive TransferAnimalsAxonsDendritic CellsEncephalomyelitis, Autoimmune, ExperimentalEstrogen Receptor betaFemaleLigandsMiceMice, Inbred C57BLMice, KnockoutMyelin SheathNitrilesPropionatesSeverity of Illness IndexSpinal Cord2,3-bis(4-hydroxyphenyl)-propionitrileEstrogen Receptor betaLigandsNitrilesPropionatesTumor Necrosis Factor-alpha

Identifiers

PMID21182085
PMCPMC3042725
OpenAlexW2010232340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.